BioSpace News Archive

Biotech Bay

Vascular Dynamics Interim Data on MobiusHD Presented at TCT Conference Shows Significant Reductions in Ambulatory Systolic Blood Pressure At Six Months

The company has Initiated Pivotal Trial for the MobiusHD in the US and EU

October 30, 2017

·

4 min read

FDA

Melinta Therapeutics Announces FDA Clearance of Antimicrobial Susceptibility Tests Concurrent with Baxdela Launch in the United States

The three ASTs that have been cleared are: Hardy Diagnostics’ Delafloxacin Antimicrobial Susceptibility Disk, Liofilchem® Delafloxacin MIC Test Strip, and Thermo Scientific Sensititre MIC System.

October 30, 2017

·

7 min read

Chi-Med Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately US$301.3 Million on the Nasdaq Global Select Market

Hutchison China MediTech announced today the closing of its underwritten public offering of American Depositary Shares on the Nasdaq Global Select Market, previously announced by Chi-Med on October 24, 2017, October 25, 2017 and October 27, 2017 at a price of US$26.50 per ADS.

October 30, 2017

·

7 min read

FDA

Evolve BioSystems’ Evivo Gains Health Canada Approval, Providing First International Expansion Opportunity

The license, granted by Health Canada, states that Evivo is safe to give once a day to babies under 1 year of age.

October 30, 2017

·

2 min read

Alpha Tau Medical Initiates First Clinical Trial in Italy to Treat Cancer With Alpha Radiation

The team hopes that the results from the study at IRST will further reinforce the promising preliminary results of the ongoing SCC study at the Rabin Medical Center, Israel.

October 30, 2017

·

1 min read

Cardiome Announces Commercial Launch of Xydalba in Three New European Geographies

Cardiome today announced that it has initiated the commercial launch of Xydalba in Sweden, Finland and the Republic of Ireland.

October 30, 2017

·

7 min read

Golden Meditech Announces the Proposed Voluntary Delisting of TDR on TWSE

Golden Meditech today announces that the board of directors of the Company resolved to initiate an application for the voluntary delisting of the TDR from the TWSE, the repurchase of TDR resulting from the Voluntary Delisting and the TDR conversion offer.

October 30, 2017

·

2 min read

Drug Development

Siamab Therapeutics Presents New Preclinical Safety Data for ST1 Antibody Therapeutics Program at the 2017 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

These results add to the company’s efficacy data findings showing that its anti-STn antibody therapeutics inhibit tumor progression in cell-line-derived and patient-derived xenograft (PDX) ovarian cancer and pancreatic cancer mouse models, with complete regression observed in some treatment arms.

October 30, 2017

·

4 min read

Lone Star Bio

Apollo Endosurgery Announces Presentation of the Brazilian Intragastric Balloon Consensus Statement at ObesityWeek

This presentation reported the results of a consensus meeting held in Sao Paulo, Brazil in June 2016 of 39 endoscopists with up to 17 years of experience providing intragastric balloon therapy to patients.

October 30, 2017

·

6 min read

Drug Development

SetPoint Medical Presents Early Data Showing Bioelectronic Medicine Accelerates Remyelination in Animal Model of Multiple Sclerosis

These results show promise for a possible bioelectronic treatment for MS and lay the groundwork for further studies by SetPoint.

October 30, 2017

·

3 min read